- Home
- MDXG vs BCSF Comparison
MDXG vs BCSF Comparison
Compare MDXG & BCSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- BCSF
- Stock Information
- Founded
- MDXG 2006
- BCSF 2015
- Country
- MDXG United States
- BCSF United States
- Employees
- MDXG N/A
- BCSF N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- BCSF Finance/Investors Services
- Sector
- MDXG Health Care
- BCSF Finance
- Exchange
- MDXG Nasdaq
- BCSF Nasdaq
- Market Cap
- MDXG 1.3B
- BCSF 1.1B
- IPO Year
- MDXG N/A
- BCSF 2018
- Fundamental
- Price
- MDXG $8.86
- BCSF $17.77
- Analyst Decision
- MDXG Strong Buy
- BCSF Hold
- Analyst Count
- MDXG 5
- BCSF 4
- Target Price
- MDXG $12.00
- BCSF $16.75
- AVG Volume (30 Days)
- MDXG 573.7K
- BCSF 187.0K
- Earning Date
- MDXG 02-26-2025
- BCSF 02-25-2025
- Dividend Yield
- MDXG N/A
- BCSF 10.15%
- EPS Growth
- MDXG N/A
- BCSF N/A
- EPS
- MDXG 0.52
- BCSF 1.99
- Revenue
- MDXG $342,804,000.00
- BCSF $294,257,000.00
- Revenue This Year
- MDXG $9.56
- BCSF N/A
- Revenue Next Year
- MDXG $9.19
- BCSF N/A
- P/E Ratio
- MDXG $17.41
- BCSF $8.92
- Revenue Growth
- MDXG 10.93
- BCSF 3.17
- 52 Week Low
- MDXG $5.47
- BCSF $14.78
- 52 Week High
- MDXG $10.14
- BCSF $17.97
- Technical
- Relative Strength Index (RSI)
- MDXG 44.99
- BCSF 61.05
- Support Level
- MDXG $8.50
- BCSF $16.79
- Resistance Level
- MDXG $9.36
- BCSF $17.88
- Average True Range (ATR)
- MDXG 0.27
- BCSF 0.27
- MACD
- MDXG -0.02
- BCSF 0.04
- Stochastic Oscillator
- MDXG 34.88
- BCSF 84.40
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About BCSF Bain Capital Specialty Finance Inc.
Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing predominantly in middle-market companies with between $10.0 million and $150.0 million in annual EBITDA. Its portfolio of investments includes, First Lien Senior Secured Loan, Preferred Equity, Equity Interest, and Second Lien Senior Secured Loan among others.